Cambridge Healthtech Institute’s 17th Annual
Immunology for Biotherapeutics
Advancing Immune Understanding and Modulation for Next-Generation Therapeutics
October 19, 2026
Advances in biotherapeutic development increasingly depend on a deeper understanding of immune system biology and its therapeutic manipulation. This symposium explores how adaptive and innate immune mechanisms influence the safety, efficacy, and clinical performance of emerging biologics. Covering immune modulation, immunogenicity, hypersensitivity, and next-generation antibody and cell-based therapies, presentations will highlight strategies to harness immune responses for therapeutic benefit while mitigating risk. Attendees will gain insight into translating immunological understanding into the design and development of safer, more effective biotherapeutics.
Coverage will include, but is not limited to:
- Emerging understanding of innate and adaptive immune mechanisms impacting biotherapeutic performance
- Antigen processing and presentation and implications for T cell and NK cell activation
- Regulation and therapeutic targeting of T cell subsets and immune checkpoints
- Roles of innate lymphoid cells and tissue-resident immune populations in disease and therapy
- Hypersensitivity and immune-mediated adverse responses to biologics
- Immunogenicity drivers, prediction, and clinical consequences for biopharmaceutical products
- Safety considerations for multispecific antibodies, bispecifics, and antibody-drug conjugates
- Engineering antibody-based therapeutics to modulate immune responses
- Harnessing immune mechanisms for oncology and immune-mediated disease treatment
- Advances in adoptive and immune-cell–based therapeutic strategies
- Complement biology and emerging immune regulatory pathways as therapeutic targets
- Translating immunological insight into safer and more effective next-generation biotherapeutics
The deadline for priority consideration is April 10, 2026.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: